Cargando…
Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers
Ample evidence supports the use of statin therapy for secondary prevention in patients with a history of atherosclerotic cardiovascular disease (ASCVD), but evidence is wanting in the case of primary prevention, low-risk individuals, and elderly adults 65+. Statins are effective in lowering low-dens...
Autores principales: | White, Alyssa M. B., Mishcon, Hillary R., Redwanski, John L., Hills, Ronald D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700563/ https://www.ncbi.nlm.nih.gov/pubmed/33233352 http://dx.doi.org/10.3390/jcm9113748 |
Ejemplares similares
-
Gut Microbiome: Profound Implications for Diet and Disease
por: Hills, Ronald D., et al.
Publicado: (2019) -
Improving the physician-patient cardiovascular risk dialogue to improve statin adherence
por: Casebeer, Linda, et al.
Publicado: (2009) -
The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis
por: Soulaidopoulos, Stergios, et al.
Publicado: (2018) -
Coronary artery calcium score plays an important role for cardiovascular risk stratification in the statin benefit groups of asymptomatic individuals
por: Lee, Dong-Hyeon, et al.
Publicado: (2017) -
Cardiovascular Risk and Statin Therapy Considerations in Women
por: Gheorghe, Gina, et al.
Publicado: (2020)